Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
Nascent Biotech (NBIO) Stock Price & Analysis
33 Followers
NBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.28
Previous Close$0.08
Volume676.51K
Average Volume (3M)83.04K
Market Cap
$14.38M
Enterprise Value$14.69M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$305.00K
Price to Earnings (P/E)-5.8
Beta-1.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding169,729,565
10 Day Avg. Volume87,243
30 Day Avg. Volume83,042
Standard Deviation0.42
R-Squared0.16
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)-3177.46
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-11.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nascent Biotech News
Ownership Overview
25.46% Insiders
0.00% Mutual Funds
0.06% Other Institutional Investors
74.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NBIO FAQ
What was Nascent Biotech Inc.’s price range in the past 12 months?
Nascent Biotech Inc. lowest stock price was $0.03 and its highest was $0.28 in the past 12 months.
What is Nascent Biotech Inc.’s market cap?
Currently, no data Available
When is Nascent Biotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nascent Biotech Inc.’s earnings last quarter?
Currently, no data Available
Is Nascent Biotech Inc. overvalued?
According to Wall Street analysts Nascent Biotech Inc.’s price is currently Overvalued.
Does Nascent Biotech Inc. pay dividends?
Nascent Biotech Inc. does not currently pay dividends.
What is Nascent Biotech Inc.’s EPS estimate?
Nascent Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nascent Biotech Inc. have?
Nascent Biotech Inc. has 169,729,570 shares outstanding.
What happened to Nascent Biotech Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nascent Biotech Inc.?
Currently, no hedge funds are holding shares in NBIO
---
Nascent Biotech Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.33%
Trailing 12-Months
Company Description
Nascent Biotech Inc.
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded in July 15, 2014 and is headquartered in San Diego, CA.
---
Technical Analysis
---